Trios from 200 families who have lost a child to SUDC to be sequenced on PacBio’s Revio system with SPRQ-Nx chemistry, enabling increased diagnostic yield for grieving families MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s research effort led […]

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studies BOSTON & LAUSANNE, Switzerland — Genialis, the RNA biomarker company, today announced that Swiss-based biopharmaceutical company Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support biomarker discovery and […]

Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia System strengthens Taiwan’s capabilities in protein drug discovery research Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, […]

WUXI, China — IAS ANALYSIS, a global provider of Process Analytical Technology (PAT) and Near-Infrared (NIR) spectroscopy solutions, continues to strengthen its international footprint with the successful installment of ten online NIR analyzers across key agricultural and food processing regions worldwide. The projects span from olive oil mills across Southern Europe to a large-scale palm […]

Seoul, South Korea — Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced today that it has implemented CDD Vault®, the secure, cloud-based research informatics platform from Collaborative Drug Discovery (CDD). The system will support Aston Sci.’s rapidly expanding research programs enabled by its advanced Th-Vac® epitope-screening platform, which is bolstered […]

Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Tahoe Therapeutics has selected Parse’s GigaLab to generate data for its upcoming 300M cell project. Tahoe will use its proprietary Mosaic technology to […]

Mike Hampton, Chief Commercial Officer, Sapio Sciences Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program. The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale […]

ETTLINGEN, Germany — Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: AVANCE NEO 1 GHz system with a range of liquids and solids NMR probes for biological and material science applications In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered […]

Toronto — BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada. “Seeing Merck’s teams use ASCEND to unravel disease biology, strengthen hypotheses, and make more evidence-driven decisions underscores the real scientific value AI can […]

BOSTON — Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory (PNNL) a four-year, up to $47M contract to co-design, build, and integrate a High‑Throughput Automated Phenotyping Platform (HTP‑APP) in support of the Microbial Molecular Phenotyping Capability (M2PC). The platform, selected through a competitive procurement process, is intended to […]